Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. (Record no. 26884016)

MARC details
000 -LEADER
fixed length control field 00795 a2200217 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517140641.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1178-6930
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2147/OTT.S103864
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Alakel, Nael
245 00 - TITLE STATEMENT
Title Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. OncoTargets and therapy
Date of publication, distribution, etc. 2017
300 ## - PHYSICAL DESCRIPTION
Extent 597-605 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Middeke, Jan Moritz
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schetelig, Johannes
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bornhäuser, Martin
773 0# - HOST ITEM ENTRY
Title OncoTargets and therapy
Related parts vol. 10
-- p. 597-605
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2147/OTT.S103864">https://doi.org/10.2147/OTT.S103864</a>
Public note Available from publisher's website

No items available.